Relapsed, Refractory or Plateau Phase Multiple Myeloma
1 clinical trials · Condition
◉ Watch Relapsed, Refractory or Plateau Phase Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma (NCT00429949) | Washington University School of Medicine | 2007-01-01 |
Track Relapsed, Refractory or Plateau Phase Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.